| Filed On | Filing |
|---|---|
| 27 Oct 2026 |
8-K: Unregistered Sales of Equity Securities; Other Events
CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE THAT THE ISSUER TREATS AS PRIVATE OR CONFIDENTIAL |
| 21 Oct 2026 | FORM 424B3 |
| 21 Oct 2026 | D |
| 20 Oct 2026 |
8-K: Unregistered Sales of Equity Securities
From September 14, 2026 through October 15, 2026, Conexeu Sciences Inc. (the "Company") has issued an aggregate of (i) 1,290,000 unregistered shares of common stock, (ii) 1,333,333 units (each, a "Unit"), with each Unit consisting of one... |
| 19 Oct 2026 |
Form 4: Purcell Lynn Sebastian, Director
Bought 166,666 shares ($500K) · Acquired 166,666 Warrant (Open Market Purchase) |
| 29 Sep 2026 | D |
| 28 Sep 2026 |
Form 4: Bogart David Robert, Director
Received 750,000 shares by exercise or conversion ($750) |
| 15 Sep 2026 | FORM 424B3 |
| 15 Sep 2026 | D |
| 15 Sep 2026 | SCHEDULE 13D/A |
| 15 Sep 2026 |
Form 4: Sharpe Jeffrey Nathan, Director
Received 500,000 shares by exercise or conversion ($500) |
| 14 Sep 2026 | FORM 10-Q |
| 10 Sep 2026 | FORM 424B3 |
| 10 Sep 2026 |
8-K: Unregistered Sales of Equity Securities
From June 18, 2026 through September 4, 2026, Conexeu Sciences Inc. (the "Company") has issued an aggregate of 1,448,368 unregistered shares of common stock and 202,500 unregistered common stock purchase warrants pursuant to various agre... |
| 09 Sep 2026 |
Form 4/A: Purcell Lynn Sebastian, Director
Received 217,608 shares by exercise ($500K) |
| 09 Sep 2026 |
Form 4: Purcell Lynn Sebastian, Director
Received 217,608 shares by exercise ($500K) · Acquired 217,608 Warrant (In/At-money Exercise) ($218) |
| 04 Sep 2026 | SCHEDULE 13G/A |
| 04 Sep 2026 | SCHEDULE 13G |
| 31 Aug 2026 | D |
| 18 Aug 2026 | SCHEDULE 13D |
Loading...
